Skip to content

LABORAX: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LABORAX

BE 0794.339.532
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€20,608
2024 · €17,190+€3,418
Equity
€54,686
2024 · €34,078+€20,608
Cash
€39
2024 · €26+€13
Balance sheet total
€114,470
2024 · €45,076+€69,394

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€69,381

    up €69,381 (+154.0%), from €45,050 to €114,431

    of which Other amounts receivable: +€69,428

Equity and liabilities
  • Other debts +€45,627

    up €45,627 (+7148.4%), from €638 to €46,265

  • Profit (loss) carried forward +€20,608

    up €20,608 (+66.3%), from €31,078 to €51,686

  • Tax, wage and social debts +€3,159

    up €3,159 (+30.5%), from €10,359 to €13,519

Income statement
  • Financial income +€2,960

    up €2,960 (+217.6%), from €1,360 to €4,320

  • Gross operating margin +€1,134

    up €1,134 (+4.9%), from €23,161 to €24,295

  • Taxes +€616

    up €616 (+8.9%), from €6,884 to €7,500

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €17,190
Gross operating margin +€1,134
Other operating charges -€12
Financial income +€2,960
Financial charges -€48
Taxes -€616
Result 2025 €20,608

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€13
Investment €0
Financing €0
Cash 2024 €26
Net result for the year +€20,608
Receivables within one year -€69,381
Tax, wage and social debts +€3,159
Other debts +€45,627
Cash 2025 €39
Every line side by side 26 lines
Line Code 2024 2025 Change %
Total assets 20/58 €45,076 €114,470 +€69,394 +154.0%
Current assets 29/58 €45,076 €114,470 +€69,394 +154.0%
Amounts receivable within one year 40/41 €45,050 €114,431 +€69,381 +154.0%
Trade receivables 40 €47 - -€47
Other amounts receivable 41 €45,003 €114,431 +€69,428 +154.3%
Cash at bank and in hand 54/58 €26 €39 +€13 +51.3%
Total equity and liabilities 10/49 €45,076 €114,470 +€69,394 +154.0%
Equity 10/15 €34,078 €54,686 +€20,608 +60.5%
Contributions 10/11 €3,000 €3,000 = 0.0%
Profit (loss) carried forward 14 €31,078 €51,686 +€20,608 +66.3%
Amounts payable 17/49 €10,998 €59,784 +€48,786 +443.6%
Amounts payable within one year 42/48 €10,998 €59,784 +€48,786 +443.6%
Taxes, remuneration and social security 45 €10,359 €13,519 +€3,159 +30.5%
Taxes 450/3 €10,359 €13,519 +€3,159 +30.5%
Other amounts payable 47/48 €638 €46,265 +€45,627 +7148.4%
Other operating charges 640/8 €387 €400 +€12 +3.2%
Gross operating margin 9900 €23,161 €24,295 +€1,134 +4.9%
Operating profit (loss) 9901 €22,773 €23,895 +€1,122 +4.9%
Financial income 75/76B €1,360 €4,320 +€2,960 +217.6%
Recurring financial income 75 €1,360 €4,320 +€2,960 +217.6%
Financial charges 65/66B €59 €107 +€48 +81.5%
Recurring financial charges 65 €59 €107 +€48 +81.5%
Profit (loss) for the period before taxes 9903 €24,075 €28,108 +€4,033 +16.8%
Income taxes 67/77 €6,884 €7,500 +€616 +8.9%
Profit (loss) for the period 9904 €17,190 €20,608 +€3,418 +19.9%
Profit (loss) for the period to be appropriated 9905 €17,190 €20,608 +€3,418 +19.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.